Related Experiment Video
Updated: May 27, 2026
13:18
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Therapygenetics: moving towards personalized psychotherapy treatment
Christopher G Beevers1, John E McGeary
1Department of Psychology, University of Texas at Austin, Austin, TX 78712, USA. beevers@psy.utexas.edu
Trends in Cognitive Sciences
|November 23, 2011
Summary
Genetic variations can predict how well children respond to cognitive behavior therapy (CBT) for anxiety. This finding offers insights into psychopathology and suggests including genetic assessments in future clinical trials.
Area of Science:
- Psychiatry
- Genetics
- Developmental Psychology
Background:
- Pediatric anxiety is a significant concern, impacting child development and well-being.
- Cognitive Behavior Therapy (CBT) is a common treatment, but response rates vary.
- Understanding predictors of treatment success is crucial for personalized medicine.
Discussion:
- Genetic variations may influence neurobiological pathways targeted by CBT.
- This research bridges the gap between genetic predispositions and psychosocial treatment outcomes.
- Exploring genetic underpinnings can refine our understanding of anxiety disorders' etiology.
Key Insights:
- Novel research indicates a link between specific genetic variations and treatment response in pediatric anxiety.
- Children with certain genetic profiles may benefit more or less from CBT.
- This highlights the potential for genetically informed, tailored therapeutic interventions.
Outlook:
- Future clinical trials for pediatric anxiety should incorporate genetic assessments.
- Integrating genetic data can lead to more precise and effective treatment strategies.
- This approach may advance the field of precision psychiatry for child mental health.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...